Owner LFB Biotechnologies

Inventors Beliard, Rolan; Bihoreau, Nicolas; Bourel, Dominique; Glacet, Arnaud; Nony, Emanuel; Romeuf de, Christophe

Agent Freehills

Pub. Number AU-B-2010257417

Parent 2007202060

Filing date 23 December 2010

Wipo publication date 20 January 2011

Acceptance publication date 5 April 2012

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/34 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies